Glucose Health Stock Buy Hold or Sell Recommendation
| GLUC Stock | USD 0.16 0.01 6.67% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Glucose Health is 'Strong Sell'. Macroaxis provides Glucose Health buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding GLUC positions.
Check out Glucose Health Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. In addition, we conduct extensive research on individual companies such as Glucose and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Glucose Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.
Glucose |
Execute Glucose Health Buy or Sell Advice
The Glucose recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Glucose Health. Macroaxis does not own or have any residual interests in Glucose Health or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Glucose Health's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Insignificant | Details | |
Volatility | Out of control | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | High | Details | |
Economic Sensitivity | Barely shadows the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Glucose Health Trading Alerts and Improvement Suggestions
| Glucose Health is way too risky over 90 days horizon | |
| Glucose Health has some characteristics of a very speculative penny stock | |
| Glucose Health appears to be risky and price may revert if volatility continues | |
| Glucose Health has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 1.11 M. Net Loss for the year was (338.9 K) with loss before overhead, payroll, taxes, and interest of (2.41 K). | |
| Glucose Health currently holds about 569.39 K in cash with (72.74 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.04. |
Glucose Health Returns Distribution Density
The distribution of Glucose Health's historical returns is an attempt to chart the uncertainty of Glucose Health's future price movements. The chart of the probability distribution of Glucose Health daily returns describes the distribution of returns around its average expected value. We use Glucose Health price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Glucose Health returns is essential to provide solid investment advice for Glucose Health.
| Mean Return | 1.02 | Value At Risk | -19.05 | Potential Upside | 40.00 | Standard Deviation | 16.36 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Glucose Health historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Glucose Health Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Glucose Health or Consumer Defensive sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Glucose Health's price will be affected by overall pink sheet market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Glucose pink sheet's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 1.00 | |
β | Beta against Dow Jones | 0.15 | |
σ | Overall volatility | 16.35 | |
Ir | Information ratio | 0.06 |
Glucose Health Volatility Alert
Glucose Health is showing large volatility of returns over the selected time horizon. Glucose Health is a potential penny stock. Although Glucose Health may be in fact a good instrument to invest, many penny pink sheets are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in Glucose Health. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Glucose instrument if you perfectly time your entry and exit. However, remember that penny pink sheets that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Glucose Health Fundamentals Vs Peers
Comparing Glucose Health's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Glucose Health's direct or indirect competition across all of the common fundamentals between Glucose Health and the related equities. This way, we can detect undervalued stocks with similar characteristics as Glucose Health or determine the pink sheets which would be an excellent addition to an existing portfolio. Peer analysis of Glucose Health's fundamental indicators could also be used in its relative valuation, which is a method of valuing Glucose Health by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Glucose Health to competition |
| Fundamentals | Glucose Health | Peer Average |
| Return On Equity | -0.5 | -0.31 |
| Return On Asset | -0.28 | -0.14 |
| Profit Margin | (0.32) % | (1.27) % |
| Operating Margin | (0.32) % | (5.51) % |
| Current Valuation | 1.16 M | 16.62 B |
| Shares Outstanding | 4.55 M | 571.82 M |
| Shares Owned By Insiders | 10.14 % | 10.09 % |
| Shares Owned By Institutions | 0.25 % | 39.21 % |
| Price To Earning | (1.99) X | 28.72 X |
| Price To Sales | 3.42 X | 11.42 X |
| Revenue | 1.11 M | 9.43 B |
| Gross Profit | (2.41 K) | 27.38 B |
| EBITDA | (336.06 K) | 3.9 B |
| Net Income | (338.9 K) | 570.98 M |
| Cash And Equivalents | 569.39 K | 2.7 B |
| Cash Per Share | 0.04 X | 5.01 X |
| Total Debt | 332.88 K | 5.32 B |
| Current Ratio | 545.85 X | 2.16 X |
| Book Value Per Share | 0.06 X | 1.93 K |
| Cash Flow From Operations | (72.74 K) | 971.22 M |
| Earnings Per Share | (0.04) X | 3.12 X |
| Number Of Employees | 4 | 18.84 K |
| Beta | 3.12 | -0.15 |
| Market Capitalization | 2.68 M | 19.03 B |
| Total Asset | 207 K | 29.47 B |
| Retained Earnings | (5.96 M) | 9.33 B |
| Working Capital | (217 K) | 1.48 B |
| Current Asset | 207 K | 9.34 B |
| Current Liabilities | 424 K | 7.9 B |
| Z Score | -33.9 | 8.72 |
Glucose Health Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Glucose . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Glucose Health Buy or Sell Advice
When is the right time to buy or sell Glucose Health? Buying financial instruments such as Glucose Pink Sheet isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Glucose Health in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Sector ETFs Thematic Idea Now
Sector ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Sector ETFs theme has 439 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Sector ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Glucose Pink Sheet
Glucose Health financial ratios help investors to determine whether Glucose Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Glucose with respect to the benefits of owning Glucose Health security.